{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:02:28Z","timestamp":1761580948715},"reference-count":25,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2012,1,3]],"date-time":"2012-01-03T00:00:00Z","timestamp":1325548800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2013,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Epidermal growth factor receptor (EGFR) inhibitors are part of the therapeutic arsenal available for advanced cancer. However, they are frequently associated with cutaneous side\u2010effects, which can hamper compliance, lead to treatment refusal and impair quality of life.<\/jats:p><jats:p><jats:bold>Objective\u2002<\/jats:bold> To know the attitudes of French oncologists who deal with this skin toxicity. This work is one of the steps to build a therapeutic algorithm of side\u2010effects induced by EGFR inhibitors taking both evidence\u2010based medicine and standard practices into account.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Physicians completed a questionnaire as part of regional meetings, before any discussion. Questions concerned the management of 11 clinical situations in the context of EGFR inhibitor prescription.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Sixty\u2010seven questionnaires were analysed. The collaboration with dermatologists was especially planned for persisting or worsening lesions beyond 2\u2003weeks, but never considered at the time of the introduction of targeted therapy. The results demonstrated the difficulties encountered in diagnosing and grading skin lesions. Attitudes of oncologists were uniform for preventive care and management of mild lesions for which moisturizing and cyclines were widely prescribed. Significant differences appeared in the treatment of less typical cases such as the involvement of skin appendages, secondary infections of folliculitis or cases associated with radiodermatitis. Discrepancies existed also for what to do in relation with maintenance or interruption of EGFR inhibitor mainly if they were responsible for severe lesions.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> This original survey emphasizes the interest of greater multidisciplinary collaboration and the necessity to harmonize practice.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2011.04421.x","type":"journal-article","created":{"date-parts":[[2012,1,3]],"date-time":"2012-01-03T07:15:21Z","timestamp":1325574921000},"page":"419-429","source":"Crossref","is-referenced-by-count":18,"title":["Survey on the management of skin toxicity associated with EGFR inhibitors amongst French Physicians"],"prefix":"10.1111","volume":"27","author":[{"given":"L","family":"Peuvrel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Bachmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z","family":"Reguiai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.B.","family":"Bachet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.J.","family":"Bensadoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Bouch\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ychou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Dr\u00e9no","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Regional expert groups PROCUR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,3]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1986.39"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.00.6916"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(09)70044-9"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp439"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09214.x"},{"issue":"5","key":"e_1_2_6_7_2","first-page":"34","article-title":"Dermatologic toxicities associated with EGFR inhibitors: the clinical psychologist\u2019s perspective. Impact on health\u2010related quality of life and implications for clinical management of psychological sequelae","volume":"11","author":"Wagner LI","year":"2007","journal-title":"Oncology (Williston Park)"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.3816\/CLC.2008.n.010"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.04.062"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.11-9-1010"},{"key":"e_1_2_6_11_2","first-page":"194","article-title":"The growing importance of skin toxicity in EGFR inhibitor therapy","volume":"23","author":"Lacouture ME","year":"2009","journal-title":"Oncology (Williston Park)"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(05)70243-6"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1159\/000277656"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1159\/000112795"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gcb.2009.02.008"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-5-610"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.3747\/co.v16i1.361"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq387"},{"key":"e_1_2_6_19_2","unstructured":"NCI Common Terminology Criteria for Adverse Events (CTCAE) v4.http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm(last accessed 22 December 2011)."},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-009-0744-x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23621"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.7828"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.6987"},{"issue":"15","key":"e_1_2_6_24_2","article-title":"CYTAR: A randomized clinical trial evaluating the preventive effect of doxycycline on erlotinib\u2010induced folliculitis in non\u2010small cell lung cancer patients (abstract). ASCO Annual Meeting Proceedings Part 1","volume":"28","author":"Deplanque G","year":"2010","journal-title":"J Clin Oncol"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi279"},{"issue":"11","key":"e_1_2_6_26_2","first-page":"22","article-title":"Clinical management of EGFRI dermatologic toxicities: the European perspective","volume":"21","author":"Segaert S","year":"2007","journal-title":"Oncology (Williston Park)"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2011.04421.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2011.04421.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T23:48:24Z","timestamp":1697327304000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2011.04421.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,3]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["10.1111\/j.1468-3083.2011.04421.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04421.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"type":"print","value":"0926-9959"},{"type":"electronic","value":"1468-3083"}],"subject":[],"published":{"date-parts":[[2012,1,3]]}}}